comprehensive
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: Novo Holdings to buy drug manufacturer Catalent in $16.5B deal
Next article: Novo Holdings to buy drug manufacturer Catalent in $16.5B deal
knowledge
focus
-
Novo Holdings to buy drug manufacturer Catalent in $16.5B deal
2025-09-30 07:14 -
A common UTI test for kids haunts adults as a traumatic 'nightmare'
2025-09-30 07:00 -
Problems with a popular proposal to regulate AI in health care
2025-09-30 06:57 -
The CDC's new social media misinformation war
2025-09-30 06:39 -
Why CTE doesn’t keep Americans from enjoying the Super Bowl
2025-09-30 06:28 -
AI gets buy
2025-09-30 06:27